Merck KGaA secures CRISPR patents in Japan and Singapore
27-11-2019
David Tonelson / Shutterstock.com
UK-based pharmaceutical manufacturer Comb International, owner of the ‘Vagisil’ trademark, has successfully challenged the ‘Vagisan’ trademark at the Intellectual Property Office Singapore (IPOS).
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Comb International, Vagisil, Vagisan, trademark, Intellectual Property Office Singapore, IPOS
